drugset / Trial / NCT03509870
Bone Marrow Derived Allogeneic Mesenchymal Stromal Cells to Non-healing Diabetic Foot Wounds
Phase 1
Terminated
2 enrolled
Steno Diabetes Center Copenhagen
Leiden University Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
examine safety of topical application of single dose allogeneic bone marrow derived mesenchymal stromal cells to non-healing diabetic foot ulcers
Timeline
- Start
- 2018-06-01
- Primary completion
- 2020-04-01
- Completion
- 2020-04-01
Outcome
Outcome not reported
Stopped (Enrollment): “study stopped because of lack of recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORBCEL-M | Cell therapy | — | Topical |